News Center
News Center

Beijing Economic Development Zone issued policies to support the high-quality development of high-end medical equipment intelligent manufacturing industry


On the morning of February 14, the Beijing Economic and Technological Development Zone released the Action Plan of the Beijing Economic and Technological Development Zone to Accelerate the Construction of the Global "Intelligent Manufacturing of New Drugs" Industry Highland (2023-2025) and related industrial support policies. According to the newly released Action Plan, the scale of the bio-pharmaceutical and health industry in Beijing Economic and Technological Development Zone will exceed 200 billion yuan by 2025, the total number of enterprises above the designated size will exceed 120, the number of listed enterprises will exceed 30, and innovative breakthroughs will be formed in cutting-edge tracks such as intelligent manufacturing of high-end medical equipment, and more than 100 Class II and Class III medical device products will be newly declared, so as to build a global industrial highland of "intelligent manufacturing of new drugs".

In order to implement the Action Plan, the Economic Development Zone has established a 1+2 policy system. "1" is the universal policy of the biomedical and health industry ("Several Measures of Beijing Economic and Technological Development Zone to Promote the High-quality Development of the Medical and Health Industry", hereinafter referred to as "Measures of the Medical and Health Industry"), and "N" is the special policy of subdividing the track. At the high-end medical equipment track, the special policy of "Beijing Economic and Technological Development Zone's Several Measures to Promote the High-quality Development of High-end Medical Equipment Intelligent Manufacturing Industry" (hereinafter referred to as "High-end Medical Equipment Intelligent Manufacturing Measures") was released.


In terms of promoting the high-quality development of the medical and health industry, the Measures for the Medical and Health Industry proposed that for the first time, the medical device products that obtained the Class II and Class III medical device registration certificates, the one-time capital reward for industrialization in the region was determined to be 5 million yuan, and the single enterprise should not exceed 10 million yuan/year. According to the statistics of MDCLOUD (Medical Device Data Cloud), in 2022, a total of 21 innovative medical devices were approved in Beijing, including 1 Class II device and 20 Class III devices.

For the implementation of international teams, pharmaceutical and medical device enterprises or projects with global patents, which are expected to make major breakthroughs and have strong international competitiveness, a maximum subsidy of 20 million yuan will be given according to the proportion of 20% of the new fixed assets investment in that year; Enterprises participate in the centralized procurement of drugs and medical devices in the country and Beijing, and the first successful product of industrialization in the region will be awarded a maximum of 3 million yuan according to the proportion of 3% of the total bid price. Enterprises allocate medical equipment, R&D and pilot equipment through financial leasing, and give financial subsidies according to a certain proportion of equipment leasing costs. Support medical device R&D enterprises to authorize multinational companies to carry out technical cooperation and product development and other commercial cooperation. A one-time reward will be given at the rate of 20% of the down payment for a single variety, with a maximum support of 5 million yuan. For the products approved by FDA, EMA, CE, PMDA, WHO, PIC/S and other institutions for the first time and qualified for overseas listing and sold, a one-time financial reward will be given at the ratio of 1:1 of the actual sales.

In terms of promoting the high-quality development of high-end medical equipment intelligent manufacturing industry, the Measures for Intelligent Manufacturing of High-end Medical Equipment proposed a one-time reward of 3 million yuan for the first time to enter the special review procedure of national innovative medical equipment. For enterprises with independent intellectual property rights, which have obtained Class III medical device registration certificate for the first time and are industrialized in the zone, a maximum reward of 5 million yuan will be given at the rate of 30% of new fixed assets investment, and each enterprise will not exceed 20 million yuan/year. Financial support will be given to the "three first" innovative product application demonstration and the first set (set) project that meets the supporting conditions. Encourage the R&D and production enterprises of high-end medical equipment in the zone to purchase professional technical services on the announcement technical service platform recognized by the development zone, and give the buyer financial subsidies according to a certain proportion of the service contract amount.

The person in charge of the Beijing Economic and Technological Development Zone said that the Beijing Economic and Technological Development Zone will take the conference as a new starting point, accelerate the layout of the cutting-edge technology track, and is confident to build the Beijing Economic and Technological Development Zone into an industrial highland of "intelligent manufacturing of new drugs" with global influence, create a world-class biomedical and health industry cluster, and make positive contributions to promoting the high-quality development of the capital economy.

Keyword:

支持高,新药智造

Related news


Pharynx swab test is a medical test method

Pharyngeal swab detection is a medical detection method. A small amount of secretion is dipped from the throat of the human body with a medical cotton swab, inoculated in a special culture dish, and then placed in a temperature-controlled device for culture. The patient's condition, oral mucosa and pharyngeal infection can be understood.


Medical inspection is the inspection of materials taken from human body

Medical laboratory science (MLS) is a science that carries out microbiological, immunological, biochemical, genetic, hematological, biophysical, cytological and other tests on materials from human body to provide information for prevention, diagnosis, treatment of human diseases and evaluation of human health.